BNF Chapter 13

 

1. Gastro-Intestinal System | 2. Cardiovascular System | 3. Respiratory System | 4. Central Nervous System | 5. Antimicrobials | 6. Endocrine System | 7. Obstetrics, Gynaecology & Urology | 8. Malignant Disease & Immunosuppression | 9. Nutrition & Blood | 10. Musculoskelatal & Joint Diseases | 11. Opthalmology | 12. Ear, Nose & Oropharynx | 13. Dermatology | 14. Immunology & Vaccines | 15. Anaesthetics |  GP Centre Home


Dermatology

13.1 DRY & SCALING SKIN DISORDERS
13.1.1 Emollients & barrier preparations
Primary Care GuidelineSurrey PCN Emollient and Soap Substitute Recommendations
 Guideline British Association Dermatologists [BAD ‘specials’ Guidelines]
Drug Safety UpdateParaffin-based skin emollients on dressings or clothing: fire risk
DERMATOLOGICAL DRUGS – Barrier Preparations
CAVILONCreamCAVILON is preferred choice
CONOTRANECream 100g
DRAPOLENECream
METANIUMOintment 30g
SIOPELCream 50g
SUDOCREMCream
VASOGENCream
ZINC & CASTOR OILOintment
DERMATOLOGICAL DRUGS – Emollients
Note: All bath and shower preparations are non-formulary. NHS England Do not rountinely prescribe document – 2019
EMOLLIENTS (containing Antimicrobials)
DERMOL 500Lotion 500ml
EMOLLIENTS (containing colloidal oatmeal)
Epimax OATMEAL1% Cream 500gAPC traffic light status for the management of diagnosed dermatological conditions: GREEN
EMOLLIENTS (containing paraffin)
Epimax ISOMOLGel 500gAPC traffic light status for the management of diagnosed dermatological conditions: GREEN
Epimax EXCETRACream 500gLight cream (<25% paraffin)

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

Epimax ORIGINALCream 500gLight cream (<25% paraffin)

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

Zero AQS EMOLLIENTCream 500gLight cream (<25% paraffin)

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

AQUAMAXCream 500gMedium heavy cream (>25% paraffin)

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

ZeroCREAMCream 50g, 500gMedium heavy cream (>25% paraffin)

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

 Epimax OINTMENTOintment 125g, 500gGreasy ointment

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

 ZeroDERMOintment 125g, 500gGreasy ointment

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

EMULSIFYING Ointment BPOintment 500gGreasy ointment

APC traffic light status for the management of diagnosed dermatological conditions: GREEN

50:50 LIQUID AND WHITE SOFT PARAFFINOintment 500g Very greasy ointment

APC traffic light status for the management of diagnosed dermatological conditions: GREEN


PARAFFIN -YELLOW SOFT
Ointment 15g, 500g
EMOLLIENTS (containing Urea)
IMUDERM 5%5% urea cream 500gAPC traffic light status for the management of diagnosed dermatological conditions: GREEN
FLEXITOL 10%10% urea Cream 100gAPC traffic light status for the management of diagnosed dermatological conditions: GREEN
 13.2 INFECTIONS OF THE SKIN
13.2.1 Bacterial skin infections
Aminoglycosides
NEOMYCIN 0.5 % CreamSpecial order
Nitroimidazole derivatives
METRONIDAZOLE 0.75%Gel (Rozex – licensed for rosacea), (Anabact)For malodorous wounds
MUPIROCIN 2 % Ointment (Bactroban)MRSA decolonisation
POLYFAX OintmentApproved for topical use on dermatological grafts/skin flaps
SILVER SULPHADIAZINE 1 % Cream
Fusidic Acid 2%Cream, Ointment
BNF CODE – 13.2.2 Fungal Skin Infections
Imidazole antifungals
CLOTRIMAZOLE1 % Cream, Powder, Solution (CANESTAN)
ECONAZOLE NITRATE1% Cream 30g (ECOSTATIN)
KETOCONAZOLE2 % Cream 30g

Shampoo 2% 120ml (NIZORAL)

MICONAZOLE  NITRATE2% Cream (DAKTARIN)

2% Powder (MYCIL)

Imidazole antifungals
AMOROLFINE (Loceryl)Nail lacquer
TERBINAFINE1 % Cream (Lamisil)
ANTISEPTIC & DISINFECTANT – Undecenoates
UNDECENOIC ACID WITH ZINC UNDECENOATEUndecenoic acid 10mg/1g, zine undecenoate 200mg/1g (MYCOTA) Powder
ANTISEPTIC & DISINFECTANT – Other
NYSTATIN / CHLOHEXIDINE HYDROCHLORIDE100,000 units/g / 1% creamContains antifungal
BNF CODE – 13.2.3 PARASITIC SKIN INFECTIONS
PARASITICIDAL PREPARATIONSNOTES
MALATHION0.5 % Liquid 50mlHead lice, crab lice

2nd line for scabies

 

PERMETHRIN5 % Cream

1 % Cream Rinse

1st line for scabies

crab lice

BNF CODE – 13.2.4 VIRAL SKIN INFECTIONS
ANTIVIRALS – Nucleoside analoguesNOTES
ACICLOVIR5 % Cream 10gHerpes Simplex
BNF CODE – 13.3 INFLAMMATORY SKIN CONDITIONS 
13.3.1 Eczema & Psoriasis
TOPICAL CORTICOSTEROIDS
MILD POTENCY
HYDROCORTISONE Cream 0.5%, 1%

Ointment 0.5%, 1%

FLUOCINOLONE ACETONIDESYNALAR 1 IN 10 DILUTION (0.0025%) Cream
 MODERATE POTENCY
BETAMETHASONE VALERATEBETNOVATE-RD 0.0025% Cream

BETNOVATE-RD 0.0025% Ointment

CLOBETASONE BUTYRATEEUMOVATE 0.05% Cream

EUMOVATE 0.05% Ointment

FLUDROXYCORTIDEHAELAN Cream  60g
HAELAN 4micrograms/cm2 Tape
FLUOCINOLONE ACETONIDESYNALAR 1 IN 4 DILUTION (0.00625%) Cream
POTENT
BETAMETHASONE DIPROPRIONATEDIPROSONE 0.05% Cream

DIPROSONE 0.05% Ointment

BETAMETHASONE VALERATEBETNOVATE 0.1% Cream

BETNOVATE 0.1% Ointment

HYDROCORTISONE BUTYRATELOCOID 0.1% Cream

LOCOID 0.1% Ointment

FLUOCINOLONE ACETONIDESYNALAR 0.025% Cream

SYNALAR 0.025% Gel

SYNALAR 0.025% Ointment

FLUTICASONE PROPIONATECUTIVATE 0.05% Cream
MOMETASONE FUROATEELOCON Cream

ELOCON Ointment

VERY POTENT
CLOBETASOL PROPRIONATEDERMOVATE 0.05% Cream

DERMOVATE 0.05% Ointment

SCALP APPLICATIONS
BETAMETHASONE VALERATEMousse 0.12%

Scalp Application 0.1%

CLOBETASOL PROPRIONATEScalp Application 0.05%
MOMETASONE FUROATEScalp Lotion 0.1%
BETAMETHASONE DIPROPRIONATE 0.05%, SALICYLIC ACID 2%DIPROSALIC Scalp application
ANTIMICROBIAL/STEROID COMBINATION PRODUCTS
MILD POTENCY
Hydrocortisone 1% + Miconazole Nitrate 2%DAKTACORT Ointment
Hydrocortisone 1% + Clotrimazole 1% CANESTAN HC Cream
Hydrocortisone 1% + Fusidic Acid 2% FUCIDIN H Cream, Ointment
MODERATE POTENCY 
Clobetasone butyrate 0.05% + Oxy tetracycline + Nystatin TRIMOVATE Creamcurrently unavailable
 POTENT 
Betamethasone Valerate 0.1% + Fusidic Acid 2% FUCIBET Cream
Betamethasone 0.1% + Clioquinol 3% Cream Stains clothing
VERY POTENT
Clobetasol Propionate 0.05% + Neomycin + Nystatin Cream or Ointment
DERMOVATE Ointment 25% in WSP UNLICENSED PRODUCT
 ALPHADERM Cream 30g
Hydrocortisone 1% + Urea 10%

AUREOCORT Ointment 15g
Triamcinolone 0.1% + Chlortetracycline 3%
ANTRACEN DERIVIATIVESNOTES
DITHRANOL1 % Cream, 2 % Cream , 3 % Cream 
DITHRANOL IN LASSARS PASTE0.1%, 0.25% , 0.5%, 1%, 2%, 4%, 6%, 8%
COAL TAR PREPARATIONSNOTES

COAL TAR 

POLYTAR Emollient
ALPHOSYL Lotion
Alphosyl 2 in 1 shampoo

Solution

Emollient

Lotion 5% (Exorex)

Extract 5%

COAL TAR 5%, ACID SALICYLIC 2% in WHITE SOFT PARAFFIN Ointment
BECLOMETASONE DIPROPIONATE 25% OINTMENT in 10% COAL TAR Ointment
COAL TAR SOLN 5% ACID SAL 2% DERMOVATE OINT 25% in Y.S.P. Ointment
SYNALAR GEL MIX (St Johns Formula) Coal Tar sol. 1part, Prop. Glycol 3parts, Synalar Gel 12part
Coal Tar Shampoo20mg / 1g shampoo (T-gel)

40mg / 1ml (Polytar)

50mg / 1g (Alphsyl 2 in 1)

Capsal shampoo

Coal Tar Extract 2%DERMOVATE Cream 60% in PROPYLENE GLYCOL
DRUGS AFFECTING THE IMMUNE RESPPONSENOTES
Calcinurin Inhibitors & Related Drugs
PIMECROLIMUS Cream 1%RESTRICTED for DERMATOLOGY CONSULTANT use only
TACROLIMUS Ointment 0.03%, 0.1%RESTRICTED for DERMATOLOGY CONSULTANT use only.See NICE Guidance
CYTOKINE MODULATORS
 PCN Psoriasis Treatment Pathway (Jul 17)
Biologics should be prescribed by brand. The brand providing best value in local health economy should be prescribed for all new patients. Following consent from existing patients, biologics should be switched to the brand providing the best value in local health economy.
BRODALUMAB

210mg/1.5ml solution for injection pre-filled syringes

Prescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning through CCGs (Blueteq).

TA511 Brodalumab for treating moderate to severe plaque psoriasis

CERTOLIZUMAB

200mg / ml pre-filed injection

NICE TA 574: Certolizumab pegol for treating moderate to severe plaque psoriasis
DUPILUMAB

300mg/2ml, 200mg/1.14ml pre-filled syringes

Prescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning through CCGs (Blueteq).

NICE TA534: Dupilumab for treating moderate to severe atopic dermatitis

PCN Policy Statement: Dupilumab for Atopic Dermatitis

GUSELKUMABPF syringe 300mg/2mlNICE TA521: Guselkumab for treating moderate to severe plaque psoriasis

Prescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE for paediatrics but through CCGs for adults and and patients transitioning to adult services (Blueteq).

PCN Policy Statement: Guselkumab for Psoriasis

IXEKIZUMAB 80mg/ml pre-filled injectionPrescribing should be by a specialist only, in line with NICE and/or local pathways. CCG commissioned, funding is only available with the use of Blueteq initiation and continuation forms.

NICE TA 442 – Ixekizumab for treating moderate to severe plaque psoriasis

NICE TA537: Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs

RISANKIZUMAB75mg/0.83ml solution for injection pre-filled syringesPrescribing should be by a specialist only, in line with NICE and/or local pathways. CCG commissioned, funding is only available with the use of Blueteq initiation and continuation forms.

NICE TA596: Risankizumab for treating moderate to severe plaque psoriasis

APC Policy Statement: Risankizumab for plaque psoriasis

TIDRAKIZUMAB100mg / ml pre-filled injectionPrescribing should be by a specialist only, in line with NICE and/or local pathways. CCG commissioned, funding is only available with the use of Blueteq initiation and continuation forms.

NICE TA575: Tildrakizumab for treating moderate to severe plaque psoriasis

APREMILAST (OTEZLA)Tablets, Titration Pack, 30mgPrescribing should be by a specialist only, in line with NICE and/or local pathways. CCG commissioned, funding is only available with the use of Blueteq initiation and continuation forms.

NICE TA 419 (psoriasis)

Drug Safety Update – risk of suicidal thoughts and behaviour

ADALIMUMABPF pen or syringe 40mgPrescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE (IFR process) for paediatrics but through CCGs for adults and and patients transitioning to adult services (Blueteq).

NICE TA 146 -Adalimumab for the treatment of adults with psoriasis

NICE TA455 – Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

APC Policy Statement: Adalimumab biosimilar – Aug 2019

ETANERCEPTPF syringe 25mg, 50mgPrescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE (IFR process) for paediatrics but through CCGs for adults and and patients transitioning to adult services (Blueteq).

NICE TA 103 Etanercept and efalizumab for the treatment of adults with psoriasis

NICE TA455 – Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

APC Policy Statement: Etanercept biosimilar – Aug 2019

INFLIXIMABVial 100mgPrescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE for paediatrics but through CCGs for adults and and patients transitioning to adult services (Blueteq).

NICE TA 143 – Infliximab for the treatment of adults with psoriasis

Iflectra® is currently the brand providing the best value in local health economy.

APC Policy Statement: Infliximab biosimilar (August 2019)

OMALIZUMAB150 mg per 1 ml pre-filled syringePrescribing should be by a specialist only, in line with NICE and/or local pathways. CCG commissioned, funding is only available with the use of Blueteq initiation and continuation forms.

NICE TA339: Omalizumab for previously treated chronic spontaneous urticaria

SECUKINUMABInjection 150mgPrescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE for paediatrics but through CCGs for adults and and patients transitioning to adult services (Blueteq).

NICE TA350 – Secukinumab for treating moderate to severe plaque psoriasis

USTEKINUMABPF Syringe 45mg (Stelara)Prescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning from NHSE for paediatrics but through CCGs for adults (Blueteq).

NICE TA 180 Ustekinumab for the treatment of adults with moderate to severe psoriasis

NICE TA455 – Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people


CICLOSPORIN 
Capsules 10mg, 25mg, 50mg, 100mg

Solution 100mg/ml

Injection 50mg

Ciclosporin Shared Care (Rheum & Derm)
DIMETHYL FUMARATE (Skilarence)30mg & 120mg tabletsPrescribing should be by a specialist only, in line with NICE and/or local pathways. Commissioning through CCGs (Blueteq).

NICE TA475 Dimethyl fumarate for treating moderate to severe plaque psoriasis

PCN Policy statement – Dimethyl Fumarate in Psoriasis

METHOTREXATE Tablets 2.5mg

PF Syringes (Metoject)

Weekly dosing

Attention should be paid to strength & frequency of dosing

Note: interaction with trimethroprim – do not co-prescribe

PF syringes are RESTRICTED for CONSULTANT use only

Retinoid & Related Drugs
ALITRETINOIN Capsules 10mg, 30mgRESTRICTED Use.
DERMATOLOGY Only
Pregnancy Prevention Programme in placePregnancies occuring during treatment or within 1 month of treatment discontinuation should be reported to  the MHRA and the company listed in the Patient Information Leaflet.
SALICYLIC ACID PREPARATIONSNOTES
SALICYLIC ACID 20%in EMULSIFYING Ointmentunlicensed medicine
in WHITE SOFT PARAFFIN Ointmentunlicensed medicine
SULPHUR 2% in SALICYLIC ACID 2%in AQUEOUS Creamunlicensed medicine
SALICYLIC ACID 24% with ZINC OXIDE  2% PasteAlso known as Lassar’s Paste

unlicensed medicine

CALCIPOTRIOLNOTES
Calcipotriol 50micrograms / g Dovonex Ointment
Calcipotriol / Betamethasone 50micrograms / g + 0.05%

Dovobet Ointment, Gel Enstilar cutaneous foam

plaque psoriasis

Calcipotriol combination psoriasis PCN Policy Statement

BNF CODE – 13.4 PERSPIRATION 
13.4.1 Hyperhidrosis
ALUMINIUM CHLORIDE HEXAHYDRATE20 % Application
BNF CODE – 13.5 PURITIS
ANTIPRUTITICSNOTES
CALAMINELotion
CROTAMITON(Eurax) 10 % Cream
MENTHOL 1% IN AQUEOUS CREAMcream
13.6 ROSACEA & ACNE
13.6.1 ACNE
British Association Dermatologists [BAD ‘specials’ Guidelines]

Acne Treatment choices for Primary Care – November 2019

ANTI-ANDROGENSNOTES
CO-CYPRINDIOL Tablets(Dianette)
Cyproterone Acetate 2mg + Ethinyloestradiol 35 micrograms
ANTIBIOTICS FOR ACNE (Topical)NOTES
ERYTHROMCYIN2% Solution 50ml (Stiemycin)
CLINDAMYCIN1% DALACIN-T Topical solution, Lotion
ANTIBIOTICS FOR ACNE (Oral)NOTES
IMPORTANT INFO
Antibiotic Guidelines for use of the following in Acne
Oxytetracycline &Tetracycline
Doxycycline & Lymecycline
Erythromycin & Trimethoprim
Lymecycline agreed in 2004 but not previously added

NICE CKS: Oral antibiotics for acne

ANTISEPTICS & DISINFECTANTS – PeroxidesNOTES
BENZOYL PEROXIDECream 4% (Brevoxyl)
Benzoyl Peroxide 5% + Erythromycin 3%BENZAMYCIN Gel 46.6g Sachets
BENZOYL PEROXIDE and CLINDAMYCINDUAC GEL

BENZOYL PEROXIDE 5%, CLINDAMYCIN 1%

ONCE DAILY
DERMATOLOGICAL DRUGS – Anticomedonals
AZELAIC ACID 20%Cream (Skinoren)
RETINOIDS & RELATED DRUGSNOTES

ADAPALENE
0.1 % Gel
ADAPALENE /BENZOYL PEROXIDEEPIDUO

ADAPALENE 0.1%/BENZOYL PEROXIDE 2.5%

TRETINOIN0.025 % Cream  60g

0.025 % Gel 60g


ISOTRETINOIN 
Capsules 5mg, 20mg

RESTRICTED for DERMATOLOGY 
 CONSULTANT use only

BNF CODE – 13.6.2 ROSACEA
ANTHELMINTICS
IVERMECTIN10mg/1g Cream (Soolantra)PCN recommendation: Pastulopapular rosacea – after metronidazole and/or azelaic acid or as an alternative to systemic antibiotics
ORAL RETINOIDS for PSORIASISNOTES
ACITRETIN 25 mg Capsules
PHOTOCHEMOTHERAPYNOTES
METHOXYPSORALEN-8 Gel 0.005%

Tablets 10mg


RESTRICTED Use.
DERMATOLOGY Only
Unlicensed product
METHOXYPSORALEN-5Tablets 20mgUnlicensed product
BNF CODE – 13.7 SCALP & HAIR CONDITIONS
ANTISEPTICS & UNDECENOIC ACID
BNF CODE – 13.7.1 ALOPECIA
VASODILATORS
BNF CODE – 13.7.2 HIRSUTISM
VASODILATORS
BNF CODE – 13.8 SKIN CLEANSERS, ANTISEPTICS & DESLOUGHING AGENTS
ANTISEPTICS & DISINFECTANTSNOTES

POTASSIUM PERMANGANATE 400 mg Tablets (Permitabs)
OCTENISAN Antimicrobial
Wash Lotion
  Paediatric Use MRSA Decolonisation
Iodine DisinfectantsNOTES
POVIDONE IODINE10 % Ointment
Other DisinfectantsNOTES
HYDROGEN PEROXIDE20 Vols (6%) Solution

10 Vols (3%) Solution

(Stabilised) 1.5 % (Hioxyl Cream)

DESLOUGHING AGENTSNOTES
LARVAE Lucilia Sericata (STERILE)
Streptokinase + Streptodornase100000Units 25000Units
Combination Pack Powder and Solvent (VARIDASE TOPICAL)
BNF CODE – 13.8.1 Minor Cuts & Abrasions

COLLODION FLEXIBLE Solution
(100ml)
MAGNESIUM SULPHATE Paste
OPSITE DRESSING Spray
BNF CODE – 13.10 SUN PROTECTION & PHOTODAMAGE
SUNSCREEN
Anthelios® XL Melt-in cream (UVA ,UVB protection; UVB-SPF 50+) 50mlOnly for prescribing if in line with ‘ABCS’ – skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity resulting from genentic disorders or photodermatoses, including vitiligo and those resulting from radiation therapy; chronic or recurrent herpes simplex labialis.
SunsenseUltra Lotion (UVA ,UVB protection; UVB-SPF 50) 50ml roll-on

Ultra Lotion (UVA ,UVB protection; UVB-SPF 50 125mL bottle

Ultra Lotion (UVA ,UVB protection; UVB-SPF 50 500mL pump

Only for prescribing if in line with ‘ABCS’ – skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity resulting from genentic disorders or photodermatoses, including vitiligo and those resulting from radiation therapy; chronic or recurrent herpes simplex labialis.
UvistatCream (UVA ,UVB protection; UVB-SPF 30) 125ml

Cream (UVA ,UVB protection; UVB-SPF 50) 125ml

Lipscreen (UVA ,UVB protection; UVB-SPF 50) 5g

Only for prescribing if in line with ‘ABCS’ – skin protection against ultraviolet radiation in abnormal cutaneous photosensitivity resulting from genentic disorders or photodermatoses, including vitiligo and those resulting from radiation therapy; chronic or recurrent herpes simplex labialis.
PHOTODAMAGE
HYDROQUINONE 4 % Cream
HYDROQUINONE 2% in equal parts EUMOVATE + RETIN A Cream
HYDROQUINONE  in HYDROCORTISONE & RETIN A CreamHYDROQUINONE 2% and 6% in equal parts HYDROCORTISONE1% & RETIN A Cream
HYDROQUINONE 5%, RETIN A 0.1% & HYDROCORTISONE 1% Cream

METHYL-5-AMINOLEVULINATE
 Cream (Metvix)RESTRICTED for DERMATOLOGY CONSULTANT use only.
ANALGESICS – NSAIDsNOTES

Actinic Keratosis Primary Care Treatment Choices- November 2019

DICLOFENAC Sodium Gel 3% (Solaraze)RESTRICTED for DERMATOLOGY only
FLUOROURACIL Cream 5% (Efudix)RESTRICTED for DERMATOLOGY only

Green for actinic keratosis

 

PROTEIN KINASE C ACTIVATORSNOTES
BNF CODE 13.11 SUPERFICIAL SOFT-TISSUE INJURIES & SUPERFICIAL THROMBOPHLEBITIS

Heparinoid
(HIRUDOID 0.3% in Vanishing Cream)  50g

LASONIL Ointment ( 0.8% in WSP)  40g

 13.12 WARTS & CALLUSES
Immune Response ModifiersNOTES
IMIQUIMODCream 5% (Aldara®)RESTRICTED for DERMATOLOGY  CONSULTANT use only

Blue with no information sheet for Actinic Keratosis

Plant AlkaloidsNOTES
PODOPHYLLOTOXIN(CONDYLINE) 0.5 % Application

(WARTICON) 0.5 % w/v Liquid

PODOPHYLLIN IN BENZOINCOMPOUND TINCTURE 25 % Paint
Aldehyde & DerivativesNOTES
FormaldehydeVERACUR Gel  0.75%  75g
SALICYLIC ACID & DERIVATIVESNOTES
SALACTOL Paint
SALATAC Gel

SALICYLIC ACID 
 

50 % Ointment
SALICYLIC ACID 5% and DERMOVATE 25% in W/YSP Ointment
SALICYLIC ACID 5% and DERMOVATE 50% in WSP Ointment
 
SALICYLIC ACID 5% IN EMULSIFYING OINTMENT
 
SALICYLIC ACID 5% in WHITE SOFT PARAFFIN Ointment
SALICYLIC ACID 10% in WHITE SOFT PARAFFIN Ointment
SALICYLIC ACID 60% IN WHITE SOFT PARAFFIN Ointment

SALICYLIC ACID 75% in WHITE SOFT PARAFFIN Ointment

1. Gastro-Intestinal System | 2. Cardiovascular System | 3. Respiratory System | 4. Central Nervous System | 5. Antimicrobials | 6. Endocrine System | 7. Obstetrics, Gynaecology & Urology | 8. Malignant Disease & Immunosuppression | 9. Nutrition & Blood | 10. Musculoskelatal & Joint Diseases | 11. Opthalmology | 12. Ear, Nose & Oropharynx | 13. Dermatology | 14. Immunology & Vaccines | 15. Anaesthetics |  GP Centre Home